Patel N, Adatia R, Mellemgaard A, Jack R, Møller H
King's College London, Pharmaceutical Science Research Division, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, UK.
Br J Cancer. 2007 Mar 26;96(6):886-90. doi: 10.1038/sj.bjc.6603659. Epub 2007 Mar 6.
Factors influencing the use of chemotherapy for the initial (6 months) treatment of lung cancer in South East England were investigated. The variables explored as possibly influencing the use of chemotherapy were sex, age, the year of diagnosis, the type of lung cancer, the stage, the index of multiple deprivation and the cancer network of residence. Chi2 analysis and multivariate logistic regression models were used to examine the effect of each of the variables on the use of chemotherapy. The results showed a highly significant trend in use of chemotherapy over time; the adjusted proportion of patients receiving chemotherapy increasing from 13.6% in 1994 to 29.3% in 2003. However, age, cancer network and type of lung cancer had the strongest influence on the use of chemotherapy. This finding is important when we consider that the NHS Cancer Plan aims at improving inequalities in cancer care in the UK.
对影响英格兰东南部肺癌初始(6个月)治疗中化疗使用的因素进行了调查。探讨的可能影响化疗使用的变量包括性别、年龄、诊断年份、肺癌类型、分期、多重贫困指数以及居住的癌症网络。采用卡方分析和多变量逻辑回归模型来检验每个变量对化疗使用的影响。结果显示,随着时间推移,化疗使用呈现出高度显著的趋势;接受化疗患者的校正比例从1994年的13.6%增至2003年的29.3%。然而,年龄、癌症网络和肺癌类型对化疗使用的影响最为强烈。当我们考虑到英国国家医疗服务体系癌症计划旨在改善癌症护理方面的不平等现象时,这一发现具有重要意义。